S&P 500

7,580.07

-140.32

-1.82%

Dow 30

51,770.31

-572.25

-1.09%

Nasdaq

25,437.00

-747.73

-2.86%

Russell 2000

2,811.84

-47.37

-1.66%

10-Yr Bond

4.9290

-0.0600

-1.20%

VIX

19.42

+2.22

+12.91%

Gold

3,898.90

-132.50

-3.29%

Bitcoin USD

77,702.59

+306.88

+0.40%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

HKSE - Delayed Quote HKD

Lee's Pharmaceutical Holdings Limited (0950.HK)

1.030 -0.025 (-2.37%)

At close: October 30 at 4:08:06 PM GMT+8

Loading Chart for 0950.HK

Chart Range Bar

Interval:

In partnership with ChartIQ

1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China and Southeast Asia

Ashlins Pharmaceuticals and Lee's Pharm Announce Exclusive License and Supply Agreement Valued at Up to $31 Million

Undiscovered Gems in Global Markets for January 2026

Exploring Undiscovered Gems In Global Markets This January 2026

Mobilize your Website

View Site in Mobile | Classic

Share by:

U.S. markets closed

Lee's Pharmaceutical Holdings Limited (0950.HK)

Recent News

1cBio and Lee's Pharmaceutical Holdings Limited Enter into Exclusive Licensing Agreement to Develop and Commercialize 1cBio's PARP1 Inhibitor OC-3 for Oncology in Greater China and Southeast Asia

Ashlins Pharmaceuticals and Lee's Pharm Announce Exclusive License and Supply Agreement Valued at Up to $31 Million

Undiscovered Gems in Global Markets for January 2026

Exploring Undiscovered Gems In Global Markets This January 2026

Related Tickers